We were fortunate to catch up with European editorial board member Dawn Langdon (Royal Holloway University of London, UK). She talked to us about a clinical tool she developed called BICAMS (Brief international Cognitive Assessment for Multiple Sclerosis), it’s importance and clinical impact so far, as well as next steps.
Questions
1. Could you tell us a little about BICAMS (Brief International Cognitive Assessment for Multiple Sclerosis [MS])? (0:04)
2. What impact has BICAMS made on the MS community so far? (0:57)
3. Could you tell us about your latest project – MS Trajectories? (2:11)
Speaker disclosure: Dawn Langdon has nothing to disclose in relation to this video interview.
Filmed at the 5th Congress of the European Academy of Neurology (EAN), Oslo, Norway, June 2019.
